Fig. 4.
Fig. 4. Immunoreactivity of eotaxin in CTCL. / (A) Eotaxin/CCL11 immunoreactivity in cryosection of CD30−CTCL with the use of the alkaline phosphatase/anti–alkaline phosphatase method. Eotaxin/CCL11 is present only in connective tissue cells; tumor cell staining is negative. Original magnification, × 400. (B) Eotaxin/CCL11 immunoreactivity in cryostat section of CD30+ large-cell CTCL with the use of the alkaline phosphatase/anti–alkaline phosphatase method. Eotaxin/CCL11 is present in connective tissue cells and tumor cells, which were CD30+ in serial sections (data not shown). Original magnification, × 400.

Immunoreactivity of eotaxin in CTCL.

(A) Eotaxin/CCL11 immunoreactivity in cryosection of CD30CTCL with the use of the alkaline phosphatase/anti–alkaline phosphatase method. Eotaxin/CCL11 is present only in connective tissue cells; tumor cell staining is negative. Original magnification, × 400. (B) Eotaxin/CCL11 immunoreactivity in cryostat section of CD30+ large-cell CTCL with the use of the alkaline phosphatase/anti–alkaline phosphatase method. Eotaxin/CCL11 is present in connective tissue cells and tumor cells, which were CD30+ in serial sections (data not shown). Original magnification, × 400.

Close Modal

or Create an Account

Close Modal
Close Modal